Vestal Point Capital
Overview
Vestal Point Capital is an investment firm and hedge fund manager specializing in the life sciences, managing a portfolio of securities across the biotechnology, pharmaceuticals, medical devices, tools, and diagnostics sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Galecto Biotech | Nov 2025 | Private Placement | Co-investor |
| OnKure Therapeutics | Oct 2024 | Private Placement | Co-investor |
| LEXEO Therapeutics | May 2025 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Vestal Point Capital based?
Vestal Point Capital is headquartered in New York City, New York, United States.
When was Vestal Point Capital founded?
Vestal Point Capital was founded in 2023.
How many portfolio companies does Vestal Point Capital have?
Vestal Point Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Vestal Point Capital's portfolio?
Portfolio companies visible on Caplight include Galecto Biotech, OnKure Therapeutics, LEXEO Therapeutics.
What was Vestal Point Capital's most recent investment shown here?
Vestal Point Capital's most recent investment in this portfolio sample was in Galecto Biotech in 2025.
What sectors does Vestal Point Capital focus on?
Vestal Point Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Vestal Point Capital focus on?
Stage focus information for Vestal Point Capital is not publicly available.
What is Vestal Point Capital's AUM?
Vestal Point Capital's assets under management are estimated between $2.8B and $2.8B.